Not exact matches
The drugs, ipilimumab (Yervoy ®) and
nivolumab (Opdivo ®), made by Bristol - Myers Squibb (BMS), are two
immune checkpoint inhibitors that «release the brakes» on the
immune system, allowing it to mount a stronger and more effective attack against cancer.
Activity and safety of
nivolumab, an anti-PD-1
immune checkpoint inhibitor, for patients with advanced, refractory squamous non-small-cell lung cancer (CheckMate 063): a phase 2, single - arm trial.
Head and neck cancer has one currently approved immunotherapy, the
checkpoint inhibitor nivolumab (Opdivo ®) and is one of the major cancer types for which new
immune - based cancer treatments are in development.